Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 84Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/viatris-files-supplemental-new-drug-applications-to-japans-ministry-of-health-labor-and-welfare-for-the-approval-of-effexor-for-the-treatment-of-generalized-anxiety-disorder-302433284.html

PR NEWSWIRE
21 Apr 2025

https://www.prnewswire.com/news-releases/viatris-announces-positive-top-line-results-from-phase-3-study-of-effexor-in-japanese-adults-with-generalized-anxiety-disorder-gad-302270664.html

PR NEWSWIRE
09 Oct 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-31-2024-99481.pdf

FDA
31 Jul 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217767

FDA
06 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200430

FDA
04 Apr 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216044

FDA
28 Nov 2022